During the past decade, Clinical Research Center Spzoo Medic-R Spolka Komandytowa conducted 26 clinical trials. In the 10-year time frame, 26 clinical trials started and 2 clinical trials were completed, i.e. on average, 7.7% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 2 clinical trials were completed. i.e. 28.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Clinical Research Center Spzoo Medic-R Spolka Komandytowa" #1 sponsor was "Amgen" with 7 trials, followed by "Pfizer" with 4 trials sponsored, "BeiGene" with 3 trials sponsored, "Galapagos NV" with 2 trials sponsored and "Genentech, Inc." with 2 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 12 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Research Center Spzoo Medic-R Spolka Komandytowa" #1 collaborator was "Novartis" with 2 trials as a collaborator, "Gilead Sciences" with 1 trials as a collaborator and "ICON plc" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Clinical Research Center Spzoo Medic-R Spolka Komandytowa" are "Crohn's Disease" (2 trials), "Dermatitis, Atopic" (2 trials), "Migraine" (2 trials), "Ulcerative Colitis" (2 trials) and "Acute Treatment of Migraine" (1 trials). Many other conditions were trialed in "Clinical Research Center Spzoo Medic-R Spolka Komandytowa" in a lesser frequency.

Most popular intervention types in "Clinical Research Center Spzoo Medic-R Spolka Komandytowa" are "Drug" (25 trials), "Other" (4 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (17 trials), "Erenumab Dose 1" (2 trials), "Erenumab Dose 2" (2 trials), "Erenumab Dose 3" (2 trials) and "Tislelizumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Clinical Research Center Spzoo Medic-R Spolka Komandytowa" are 25 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Clinical Research Center Spzoo Medic-R Spolka Komandytowa". undefined are not yet recruiting, 9 are recruiting, 7 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 8 completed trials in Clinical Research Center Spzoo Medic-R Spolka Komandytowa, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Clinical Research Center Spzoo Medic-R Spolka Komandytowa, 1 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 17 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".